XML 25 R12.htm IDEA: XBRL DOCUMENT v3.7.0.1
7. Stock Options
6 Months Ended
Jun. 30, 2017
Notes  
7. Stock Options

7.     Stock Options

 

The Company has established a Stock Option Incentive Plan (“SIP”) to authorize the granting of stock options up to 10 percent of the total number of issued and outstanding shares of common stock to employees, directors and consultants. Upon exercise of options, shares are issued from the available authorized shares of the Company.

 

Option awards are generally granted with an exercise price equal to the fair market value of the Company’s stock at the date of grant. 

 

Effective March 21, 2017 the Company, granted 600,000 stock options to three Directors of the Company. The options are exercisable on or before March 31, 2022 at a price of $0.10 for 200,000 shares, and at a price of $0.09 for the remaining 400,000 shares.  After this grant, the Company has 5,115,000 outstanding stock options that represent 9.4% of the issued and outstanding shares of common stock. The fair value of the options was determined to be $53,557 using the Black Scholes model.  The options were fully vested upon grant and recognized as compensation expense for the quarter ended March 31, 2017.

 

The fair value of each option award was estimated on the date of the grant using the assumptions noted in the following table:

 

 

# of Options

600,000

Stock price

$0.09

Exercise price

$0.09 to $0.10

Expected volatility

235.5%

Expected dividends

-

Expected terms (in years)

5.0

Risk-free rate

1.96%

 

 

 

 

The following is a summary of the Company’s options issued under the Stock Option Incentive Plan:

 

 

 

Shares

 

Weighted Average Exercise Price

Outstanding and exercisable at December 31, 2015

3,990,000

 

0.17

Expired

(2,000,000)

 

(0.27)

Granted

2,525,000

 

0.10

Outstanding and exercisable at December 31, 2016

4,515,000

 

$ 0.08

Granted

600,000

 

0.09

Outstanding and exercisable at June 30, 2017

5,115,000

 

$0.09

 

 

The average remaining contractual term of the options outstanding and exercisable at June 30, 2017 was 3.20 years.  As of June 30, 2017, options outstanding and exercisable had a $124,210 aggregate intrinsic value based on the Company’s stock price of $0.11.